Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Live vaccines]

P Saliou1

  • 1Pasteur-Méneux Sérums et Vaccins, Marnes-la-Coquette.

La Revue Du Praticien
|June 15, 1995
PubMed
Summary
This summary is machine-generated.

Live attenuated vaccines offer robust antibody and cellular immune responses. Future developments focus on genetically stable combined vaccines using novel delivery systems like poxviruses for enhanced efficacy and safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and risk factors for retinal detachment following implantation with a multifocal or EDOF IOL: A 15-year follow-up.

Journal francais d'ophtalmologie·2025
Same author

[The scourge of vaccine tampering].

Medecine tropicale et sante internationale·2022
Same author

Bed bug infestation in a French university hospital: control strategy, financial impact and perspectives.

The Journal of hospital infection·2022
Same author

Pulvinar and pubic cartilage measurements to refine universal ultrasound screening for developmental dysplasia of the hip: Data from 1896 infant hips.

European journal of radiology·2021
Same author

[The Saga of Vaccines against Covid-19].

Bulletin de la Societe de pathologie exotique (1990)·2021
Same author

Study on the transfusion representation by nurses and midwives at the university hospital of Brest.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2020
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Vaccinology
  • Immunology
  • Microbiology

Background:

  • Live vaccines utilize attenuated viral or bacterial strains that replicate within the host, inducing both antibody and cellular immune responses.
  • Established live attenuated vaccines (measles, rubella, mumps, yellow fever) demonstrate proven efficacy.
  • The oral poliovirus vaccine, while effective, carries a rare risk of paralysis due to viral mutations.

Purpose of the Study:

  • To review the principles, applications, and future directions of live vaccine development.
  • To highlight advancements in creating genetically stable live vaccines through gene deletion and mutagenesis.
  • To explore the potential of novel combined live vaccine strategies utilizing viral or bacterial vectors.

Main Methods:

  • Review of existing literature on live attenuated vaccines.

Related Experiment Videos

  • Analysis of vaccine development strategies, including empirical attenuation, gene deletion, and directed mutagenesis.
  • Evaluation of emerging technologies for combined live vaccine design, focusing on viral vector systems.

    • Main Results:

    • Live attenuated vaccines are effective in eliciting comprehensive immune responses.
    • Genetic engineering techniques enable the development of highly stable vaccine strains, particularly for bacterial diseases.
    • Poxviruses are identified as a promising platform for developing future combined live vaccines.

    Conclusions:

    • Live attenuated vaccines remain a cornerstone of infectious disease prevention.
    • Advanced genetic engineering offers enhanced stability and safety profiles for live vaccines.
    • Next-generation live vaccines are likely to be combination products delivered via novel vector systems, with poxviruses showing significant promise.